Assignment 3, February 15th, 2022Nicholas Cetra, 7253578April L. Metzger, Adams Kusi Appiah, Christopher M. Wright, Vikram Jairam, Arya Amini, Henry S.Park, James W. Welsh, Charles R. Thomas Jr., Vivek Verma and Ethan B. Ludmir authoredfinancialrelationships between industry and principal investigators of US cooperative group randomized cancerclinical trials(2021) in order to help determine if there is bias in US cooperative group randomizedcancer clinical trials. Randomized clinical trials (RCTs) the primary method for proving the usefulness ofa therapy or intervention (Metzger et al p. 1684). This means that RTCs have the potential to affectdrug/device approval by the FDA as well as but also the development of consensus guidelines, futureRCTs, and insurance policies (p. 1684). Financial conflicts of interest (FCOIs) can adversely impact howRCT data is understood and implemented. Financial relationships with industry have the ability tosignificantly alter the presentation, tone, and interpretation of an RCT (p.1684). All among which canhave a major effect on the previously mentioned "consequences" of RCT publication (p.1684). Thepresence of FCOIs is linked to an increased likelihood of RCTs reporting positive survival findings(p.1684). The methods of this research included finding and compiling a list of all RCTs (phase II, phase
